Nicorandil has a dual mechanism of action:
This reduces myocardial oxygen demand and decreases angina frequency. It enhances exercise tolerance and lowers ischemic episodes.
Nicorandil was evaluated in major trials including the IONA study, which demonstrated a reduction in coronary events in patients with stable angina.
Clinical data support its efficacy in reducing angina frequency and improving long-term cardiovascular outcomes. It is widely used in cardiology practice.
The medication dilates coronary vessels and improves myocardial perfusion.
Take orally as prescribed by a healthcare provider, usually twice daily. Swallow with water. Dosage is individualized based on clinical response and tolerability.
Contraindications
Side effects









